4//SEC Filing
Ullman Anders 4
Accession 0001104659-23-053022
CIK 0001657312other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:23 PM ET
Size
5.8 KB
Accession
0001104659-23-053022
Insider Transaction Report
Form 4
Ullman Anders
Director
Transactions
- Award
Share Options (Right to Buy)
2023-04-28+96,000→ 96,000 totalExercise: $2.67Exp: 2033-04-27→ Ordinary Shares (96,000 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The option vests and becomes exercisable as to 25% on each of July 28, 2023, October 28, 2023, January 28, 2024 and April 28, 2024.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001836816
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 4:23 PM ET
- Size
- 5.8 KB